Clinical outcomes and costs of the use of fibrin sealant in pancreaticojejunal anastomosis after pancreaticoduodenectomy: a retrospective analysis study

•Pancreaticoduodenectomy is the treatment of choice for resectable tumors of the pancreato-duodenal confluence.•Morbidity rates remain high ranging between 30% and 50%.•Pancreatic fistula is the most feared post pancreatic surgery complication.•Studies on the effects of using fibrin sealant in pancreatic surgery are scarce and controversial.